98 related articles for article (PubMed ID: 25107843)
1. The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor.
Setia S; Nehru B; Sanyal SN
Biomed Pharmacother; 2014 Jul; 68(6):721-7. PubMed ID: 25107843
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer.
Setia S; Nehru B; Sanyal SN
Biomed Pharmacother; 2014 Oct; 68(8):1023-9. PubMed ID: 25443414
[TBL] [Abstract][Full Text] [Related]
3. Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis.
Setia S; Nehru B; Sanyal SN
Biomed Pharmacother; 2014 Feb; 68(1):119-28. PubMed ID: 24269000
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
[TBL] [Abstract][Full Text] [Related]
5. Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation.
Piplani H; Rana C; Vaish V; Vaiphei K; Sanyal SN
Biochim Biophys Acta; 2013 Nov; 1830(11):5142-56. PubMed ID: 23872169
[TBL] [Abstract][Full Text] [Related]
6. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
Vaish V; Sanyal SN
Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
[TBL] [Abstract][Full Text] [Related]
7. PTEN regulates apoptotic cell death through PI3-K/Akt/GSK3β signaling pathway in DMH induced early colon carcinogenesis in rat.
Saini MK; Sanyal SN
Exp Mol Pathol; 2012 Aug; 93(1):135-46. PubMed ID: 22561258
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of p53 and mitochondrial signaling pathway in apoptosis by a combination of COX-2 inhibitor, Celecoxib and Dolastatin 15, a marine mollusk linear peptide in experimental colon carcinogenesis.
Piplani H; Vaish V; Rana C; Sanyal SN
Mol Carcinog; 2013 Nov; 52(11):845-58. PubMed ID: 22623379
[TBL] [Abstract][Full Text] [Related]
9. Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer.
Jain S; Ghanghas P; Rana C; Sanyal SN
Cancer Invest; 2017 Aug; 35(7):473-483. PubMed ID: 28718684
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.
Mukawa K; Fujii S; Tominaga K; Yoshitake N; Abe A; Kono T; Sekikawa A; Fukui H; Ichikawa K; Tomita S; Imura J; Ono Y; Shinoda M; Hiraishi H; Fujimori T
Oncol Rep; 2008 Feb; 19(2):393-9. PubMed ID: 18202786
[TBL] [Abstract][Full Text] [Related]
12. Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-κB and an inflammatory protein, iNOS.
Piplani H; Vaish V; Sanyal SN
Eur J Cancer Prev; 2012 Nov; 21(6):511-22. PubMed ID: 22441428
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
14. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway.
Umesalma S; Sudhandiran G
Eur J Pharmacol; 2011 Jun; 660(2-3):249-58. PubMed ID: 21463623
[TBL] [Abstract][Full Text] [Related]
15. PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac.
Kaur J; Sanyal SN
Tumour Biol; 2010 Dec; 31(6):623-31. PubMed ID: 20617408
[TBL] [Abstract][Full Text] [Related]
16. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.
Josse C; Bouznad N; Geurts P; Irrthum A; Huynh-Thu VA; Servais L; Hego A; Delvenne P; Bours V; Oury C
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G229-43. PubMed ID: 24464560
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib prevents colitis associated colon carcinogenesis: an upregulation of apoptosis.
Setia S; Nehru B; Sanyal SN
Pharmacol Rep; 2014 Dec; 66(6):1083-91. PubMed ID: 25443739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
